Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Projects
Publications
Prizes
Spin-Offs
Media
Activities
Search by expertise, name or affiliation
Fortschritte bei der Systemischen Sklerose: Frühe, zielgerichtete und intensive Behandlung ist der Schlüssel zum Erfolg
Translated title of the contribution
:
Progress in Systemic Sclerosis: Early, Targeted and Intensive Therapy is the Key to Success
Gabriela Riemekasten
*
*
Corresponding author for this work
Clinic of Rheumatology
3
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Progress in Systemic Sclerosis: Early, Targeted and Intensive Therapy is the Key to Success'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Systemic Scleroderma
100%
Secondary Prevention
85%
Pulmonary Arterial Hypertension
51%
Interstitial Lung Diseases
32%
Stem Cell Transplantation
30%
Quality of Life
18%
Raynaud Disease
18%
Angiotensin Receptors
17%
Antibodies
16%
Rheumatic Diseases
15%
Ventricular Tachycardia
15%
Therapeutics
14%
Autoantibodies
13%
Fatigue
12%
Electrocardiography
11%
Immune System
11%
Depression
9%
Physicians
9%
Pain
8%
Lung
7%
Mortality
7%